Maslizan, M. (2020). Formulating and characterizing safe lipidic liquid crystalline nanoparticles of Atorvastatin and Oligomeric Proanthocyanidin for Atherosclerotic disease treatment.
シカゴスタイル引用形Maslizan, Mardhiah. Formulating and Characterizing Safe Lipidic Liquid Crystalline Nanoparticles of Atorvastatin and Oligomeric Proanthocyanidin for Atherosclerotic Disease Treatment. 2020.
MLA引用形式Maslizan, Mardhiah. Formulating and Characterizing Safe Lipidic Liquid Crystalline Nanoparticles of Atorvastatin and Oligomeric Proanthocyanidin for Atherosclerotic Disease Treatment. 2020.
警告: この引用は必ずしも正確ではありません.